0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiopulmonary Autotransfusion System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-10R2695
Home | Market Reports | Health| Medical Facilities & Services
Global Cardiopulmonary Autotransfusion System Market Insights Forecast to 2026
BUY CHAPTERS

Global Cardiopulmonary Autotransfusion System Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-10R2695
Report
June 2025
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cardiopulmonary Autotransfusion System Market Size

In 2024, the global market size of Cardiopulmonary Autotransfusion System was estimated to be worth US$ 580 million and is forecast to reach approximately US$ 683 million by 2031 with a CAGR of 2.4% during the forecast period 2025-2031.

Cardiopulmonary Autotransfusion System Market

Cardiopulmonary Autotransfusion System Market

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one"s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System.
The Cardiopulmonary Autotransfusion System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiopulmonary Autotransfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Cardiopulmonary Autotransfusion System Market Report

Report Metric Details
Report Name Cardiopulmonary Autotransfusion System Market
Forecasted market size in 2031 approximately US$ 683 million
CAGR 2.4%
Forecasted years 2025 - 2031
Segment by Type
  • Unwashed ATS
  • Washed ATS
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Cardiopulmonary Autotransfusion System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiopulmonary Autotransfusion System sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Cardiopulmonary Autotransfusion System Market size in 2031?

Ans: The Cardiopulmonary Autotransfusion System Market size in 2031 will be approximately US$ 683 million.

What is the market share of major companies in Cardiopulmonary Autotransfusion System Market?

Ans: The top 3 players occupy about 70% shares of the global market.

What is the Cardiopulmonary Autotransfusion System Market share by type?

Ans: Washed ATS is the main type, with a share about 90%.

What is the Cardiopulmonary Autotransfusion System Market share by application?

Ans: Heart Surgery is the main application, which holds a share about 35%.

Who are the main players in the Cardiopulmonary Autotransfusion System Market report?

Ans: The main players in the Cardiopulmonary Autotransfusion System Market are Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources

What are the Application segmentation covered in the Cardiopulmonary Autotransfusion System Market report?

Ans: The Applications covered in the Cardiopulmonary Autotransfusion System Market report are Heart Surgery, Great Organ Transplant Surgery, Other Surgery

What are the Type segmentation covered in the Cardiopulmonary Autotransfusion System Market report?

Ans: The Types covered in the Cardiopulmonary Autotransfusion System Market report are Unwashed ATS, Washed ATS

Recommended Reports

Blood Collection Systems

Blood Processing Equipment

Cardiac & Perfusion Devices

1 Study Coverage
1.1 Cardiopulmonary Autotransfusion System Product Introduction
1.2 Market by Type
1.2.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Market by Application
1.3.1 Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Other Surgery
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts
2.1.1 Global Cardiopulmonary Autotransfusion System Revenue 2020-2031
2.1.2 Global Cardiopulmonary Autotransfusion System Sales 2020-2031
2.2 Cardiopulmonary Autotransfusion System Market Size by Region: 2024 Versus 2031
2.3 Cardiopulmonary Autotransfusion System Sales by Region (2020-2031)
2.3.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2020-2025
2.3.2 Global Cardiopulmonary Autotransfusion System Sales Forecast by Region (2026-2031)
2.3.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2020-2031)
2.4 Cardiopulmonary Autotransfusion System Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2020-2025
2.4.2 Global Cardiopulmonary Autotransfusion System Revenue Forecast by Region (2026-2031)
2.4.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2020-2031)
3.1.1.1 Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2020-2031)
3.1.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2031)
3.1.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2020-2031)
3.1.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Type (2020-2031)
3.1.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2020-2031)
3.1.3 Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2020-2031)
3.2.1.1 Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2020-2031)
3.2.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2031)
3.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2020-2031)
3.2.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Application (2020-2031)
3.2.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2020-2031)
3.2.3 Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Unwashed ATS of Cardiopulmonary Autotransfusion System Revenue Market Share by Application
3.3.2 Washed ATS of Cardiopulmonary Autotransfusion System Revenue Market Share by Application
4 Global Cardiopulmonary Autotransfusion System by Manufacturers
4.1 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Sales (2020-2025)
4.1.1 Global Cardiopulmonary Autotransfusion System Sales by Manufacturer (2020-2025)
4.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Cardiopulmonary Autotransfusion System Manufacturers by Revenue (2020-2025)
4.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025)
4.2.2 Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturer (2020-2025)
4.3 Global Cardiopulmonary Autotransfusion System Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Cardiopulmonary Autotransfusion System Manufacturers Covered: Ranking by Revenue
4.4.2 Global Cardiopulmonary Autotransfusion System Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Product Type
4.5.1 Cardiopulmonary Autotransfusion System Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
4.5.3 Manufacturers Cardiopulmonary Autotransfusion System Product Type and Application
4.5.4 Unwashed ATS Market Sales of Cardiopulmonary Autotransfusion System by Manufacturer
4.5.5 Washed ATS Market Sales of Cardiopulmonary Autotransfusion System by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Haemonetics
5.1.1 Haemonetics Company Information
5.1.2 Haemonetics Description, Business Overview
5.1.3 Haemonetics Cardiopulmonary Autotransfusion System Products Offered
5.1.4 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Haemonetics Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.1.6 Haemonetics Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.1.7 Haemonetics Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.1.8 Haemonetics Recent Developments
5.2 Medtronic
5.2.1 Medtronic Company Information
5.2.2 Medtronic Description, Business Overview
5.2.3 Medtronic Cardiopulmonary Autotransfusion System Products Offered
5.2.4 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Medtronic Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.2.6 Medtronic Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.2.7 Medtronic Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.2.8 Medtronic Recent Developments
5.3 LivaNova
5.3.1 LivaNova Company Information
5.3.2 LivaNova Description, Business Overview
5.3.3 LivaNova Cardiopulmonary Autotransfusion System Products Offered
5.3.4 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.3.5 LivaNova Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.3.6 LivaNova Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.3.7 LivaNova Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.3.8 LivaNova Recent Developments
5.4 Fresenius Kabi
5.4.1 Fresenius Kabi Company Information
5.4.2 Fresenius Kabi Description, Business Overview
5.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Products Offered
5.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.4.6 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.4.7 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.4.8 Fresenius Kabi Recent Developments
5.5 Terumo
5.5.1 Terumo Company Information
5.5.2 Terumo Description, Business Overview
5.5.3 Terumo Cardiopulmonary Autotransfusion System Products Offered
5.5.4 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Terumo Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.5.6 Terumo Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.5.7 Terumo Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.5.8 Terumo Recent Developments
5.6 Wandong Health Sources
5.6.1 Wandong Health Sources Company Information
5.6.2 Wandong Health Sources Description, Business Overview
5.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Products Offered
5.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales by Product in 2024
5.6.6 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales by Application in 2024
5.6.7 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales by Geographic Area in 2024
5.6.8 Wandong Health Sources Recent Developments
6 North America
6.1 North America Cardiopulmonary Autotransfusion System Market Size YoY Growth 2020-2031
6.2 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
6.2.1 North America Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
6.2.2 North America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
6.3 North America Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
6.4 North America Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Cardiopulmonary Autotransfusion System Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Region
7.2.1 Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Region (2020-2031)
7.2.2 Asia-Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2020-2031)
7.3 Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
7.4 Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
8 Europe
8.1 Europe Cardiopulmonary Autotransfusion System Market Size YoY Growth 2020-2031
8.2 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
8.2.1 Europe Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
8.2.2 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
8.3 Europe Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
8.4 Europe Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Cardiopulmonary Autotransfusion System Market Size YoY Growth 2020-2031
9.2 Latin America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
9.2.1 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
9.2.2 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
9.3 Latin America Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
9.4 Latin America Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Cardiopulmonary Autotransfusion System Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
10.2.1 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
10.2.2 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
10.3 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
10.4 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Cardiopulmonary Autotransfusion System Supply Chain Analysis
11.2 Cardiopulmonary Autotransfusion System Key Raw Materials and Upstream Suppliers
11.3 Cardiopulmonary Autotransfusion System Clients Analysis
11.4 Cardiopulmonary Autotransfusion System Sales Channel and Sales Model Analysis
11.4.1 Cardiopulmonary Autotransfusion System Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Cardiopulmonary Autotransfusion System Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Cardiopulmonary Autotransfusion System Distributors
12 Cardiopulmonary Autotransfusion System Market Dynamics
12.1 Cardiopulmonary Autotransfusion System Industry Trends
12.2 Cardiopulmonary Autotransfusion System Market Drivers
12.3 Cardiopulmonary Autotransfusion System Market Challenges
12.4 Cardiopulmonary Autotransfusion System Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Cardiopulmonary Autotransfusion System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Cardiopulmonary Autotransfusion System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Cardiopulmonary Autotransfusion System Sales by Region (2020-2025) & (K Units)
 Table 5. Global Cardiopulmonary Autotransfusion System Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Cardiopulmonary Autotransfusion System Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Cardiopulmonary Autotransfusion System Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Cardiopulmonary Autotransfusion System Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Cardiopulmonary Autotransfusion System Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Cardiopulmonary Autotransfusion System Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Cardiopulmonary Autotransfusion System Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Cardiopulmonary Autotransfusion System Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Cardiopulmonary Autotransfusion System Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Cardiopulmonary Autotransfusion System Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturer (2020-2025)
 Table 18. Cardiopulmonary Autotransfusion System Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Cardiopulmonary Autotransfusion System Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Cardiopulmonary Autotransfusion System Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Cardiopulmonary Autotransfusion System Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Cardiopulmonary Autotransfusion System Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2024)
 Table 24. Cardiopulmonary Autotransfusion System Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Cardiopulmonary Autotransfusion System Market
 Table 26. Manufacturers Cardiopulmonary Autotransfusion System Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Haemonetics Company Information
 Table 29. Haemonetics Description and Business Overview
 Table 30. Haemonetics Cardiopulmonary Autotransfusion System Product
 Table 31. Haemonetics Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Haemonetics Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 33. Haemonetics Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 34. Haemonetics Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 35. Haemonetics Recent Developments
 Table 36. Medtronic Company Information
 Table 37. Medtronic Description and Business Overview
 Table 38. Medtronic Cardiopulmonary Autotransfusion System Product
 Table 39. Medtronic Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Medtronic Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 41. Medtronic Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 42. Medtronic Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 43. Medtronic Recent Developments
 Table 44. LivaNova Company Information
 Table 45. LivaNova Description and Business Overview
 Table 46. LivaNova Cardiopulmonary Autotransfusion System Product
 Table 47. LivaNova Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. LivaNova Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 49. LivaNova Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 50. LivaNova Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 51. LivaNova Recent Developments
 Table 52. Fresenius Kabi Company Information
 Table 53. Fresenius Kabi Description and Business Overview
 Table 54. Fresenius Kabi Cardiopulmonary Autotransfusion System Product
 Table 55. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Fresenius Kabi Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 57. Fresenius Kabi Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 58. Fresenius Kabi Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 59. Fresenius Kabi Recent Developments
 Table 60. Terumo Company Information
 Table 61. Terumo Description and Business Overview
 Table 62. Terumo Cardiopulmonary Autotransfusion System Product
 Table 63. Terumo Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Terumo Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 65. Terumo Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 66. Terumo Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 67. Terumo Recent Developments
 Table 68. Wandong Health Sources Company Information
 Table 69. Wandong Health Sources Description and Business Overview
 Table 70. Wandong Health Sources Cardiopulmonary Autotransfusion System Product
 Table 71. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Wandong Health Sources Sales Proportion of Cardiopulmonary Autotransfusion System by Product in 2024
 Table 73. Wandong Health Sources Sales Proportion of Cardiopulmonary Autotransfusion System by Application in 2024
 Table 74. Wandong Health Sources Sales Proportion of Cardiopulmonary Autotransfusion System by Geographic Area in 2024
 Table 75. Wandong Health Sources Recent Developments
 Table 76. North America Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
 Table 77. North America Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
 Table 78. North America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
 Table 79. North America Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
 Table 80. North America Cardiopulmonary Autotransfusion System Sales by Type (2020-2025) & (K Units)
 Table 81. North America Cardiopulmonary Autotransfusion System Sales by Application (2020-2025) & (K Units)
 Table 82. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Region (2020-2025) & (K Units)
 Table 83. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Region (2026-2031) & (K Units)
 Table 84. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2020-2025) & (US$ Million)
 Table 85. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2026-2031) & (US$ Million)
 Table 86. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Type (2020-2025) & (K Units)
 Table 87. Asia-Pacific Cardiopulmonary Autotransfusion System Sales by Application (2020-2025) & (K Units)
 Table 88. Europe Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
 Table 89. Europe Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
 Table 90. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
 Table 91. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
 Table 92. Europe Cardiopulmonary Autotransfusion System Sales by Type (2020-2025) & (K Units)
 Table 93. Europe Cardiopulmonary Autotransfusion System Sales by Application (2020-2025) & (K Units)
 Table 94. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
 Table 95. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
 Table 96. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
 Table 97. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
 Table 98. Latin America Cardiopulmonary Autotransfusion System Sales by Type (2020-2025) & (K Units)
 Table 99. Latin America Cardiopulmonary Autotransfusion System Sales by Application (2020-2025) & (K Units)
 Table 100. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
 Table 101. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
 Table 102. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
 Table 103. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
 Table 104. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Type (2020-2025) & (K Units)
 Table 105. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Application (2020-2025) & (K Units)
 Table 106. Cardiopulmonary Autotransfusion System Key Raw Materials, Industry Status and Trend
 Table 107. Cardiopulmonary Autotransfusion System Key Raw Materials and Upstream Suppliers
 Table 108. Cardiopulmonary Autotransfusion System Clients Status and Trend
 Table 109. Cardiopulmonary Autotransfusion System Typical Clients
 Table 110. Cardiopulmonary Autotransfusion System Distributors
 Table 111. Cardiopulmonary Autotransfusion System Market Trends
 Table 112. Cardiopulmonary Autotransfusion System Market Drivers
 Table 113. Cardiopulmonary Autotransfusion System Market Challenges
 Table 114. Cardiopulmonary Autotransfusion System Market Restraints
 Table 115. Research Programs/Design for This Report
 Table 116. Key Data Information from Secondary Sources
 Table 117. Key Data Information from Primary Sources
 Table 118. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Cardiopulmonary Autotransfusion System Product Picture
 Figure 2. Global Cardiopulmonary Autotransfusion System Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type in 2024 & 2031
 Figure 4. Unwashed ATS Product Picture
 Figure 5. Washed ATS Product Picture
 Figure 6. Global Cardiopulmonary Autotransfusion System Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application in 2024 & 2031
 Figure 8. Heart Surgery
 Figure 9. Great Organ Transplant Surgery
 Figure 10. Other Surgery
 Figure 11. Cardiopulmonary Autotransfusion System Report Years Considered
 Figure 12. Global Cardiopulmonary Autotransfusion System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Cardiopulmonary Autotransfusion System Market Size 2020-2031 (US$ Million)
 Figure 14. Global Cardiopulmonary Autotransfusion System Sales 2020-2031 (K Units)
 Figure 15. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2020-2031)
 Figure 17. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Cardiopulmonary Autotransfusion System Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 20. Global Cardiopulmonary Autotransfusion System Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Cardiopulmonary Autotransfusion System Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Cardiopulmonary Autotransfusion System Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 23. Unwashed ATS of Cardiopulmonary Autotransfusion System Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Washed ATS of Cardiopulmonary Autotransfusion System Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Cardiopulmonary Autotransfusion System Sales Share by Manufacturer in 2024
 Figure 26. Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Unwashed ATS Market Sales Proportion by Manufacturer in 2024
 Figure 28. Washed ATS Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Cardiopulmonary Autotransfusion System Revenue 2020-2031 (US$ Million)
 Figure 30. North America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
 Figure 31. North America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
 Figure 37. Europe Cardiopulmonary Autotransfusion System Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
 Figure 39. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
 Figure 41. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Cardiopulmonary Autotransfusion System Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
 Figure 52. Cardiopulmonary Autotransfusion System Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Cardiopulmonary Autotransfusion System Raw Materials by Region in 2024
 Figure 54. Cardiopulmonary Autotransfusion System Distribution Channels
 Figure 55. Global Cardiopulmonary Autotransfusion System Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Cardiopulmonary Autotransfusion System Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Secure Hospital Communications Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H6366
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Direct To Consumer Telehealth Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I2436
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Healthcare API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10N6171
Thu Sep 11 00:00:00 UTC 2025

Add to Cart